Jove
Visualize
Contact Us
  1. Home
  3. Gastric Cancer Risk In Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study In The Netherlands.
  1. Home
  3. Gastric Cancer Risk In Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study In The Netherlands.

Related Concept Videos

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.

Annemarie C de Vries1, Nicole C T van Grieken, Caspar W N Looman

  • 1Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. A.C.deVries@erasmusmc.nl

Gastroenterology
|April 9, 2008

View abstract on PubMed

Summary
This summary is machine-generated.

Patients with precancerous gastric lesions face a significant risk of developing gastric cancer. Current surveillance practices are inconsistent with this risk, necessitating the development of new guidelines.

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Gastric adenocarcinoma development follows a cascade of precursor lesions including atrophic gastritis, intestinal metaplasia, and dysplasia.
  • Quantifying gastric cancer risk in patients with these premalignant lesions remains unclear, leading to controversial endoscopic surveillance practices, particularly in Western populations.

Purpose of the Study:

  • To analyze current endoscopic surveillance practices for patients diagnosed with premalignant gastric lesions.
  • To determine the gastric cancer risk associated with various stages of premalignant gastric lesions.

Main Methods:

  • Utilized the Dutch nationwide histopathology registry (PALGA) to identify patients with a first diagnosis of premalignant gastric lesions between 1991 and 2004.
  • Evaluated follow-up data until December 2005 to assess surveillance rates and gastric cancer incidence.

Main Results:

  • Identified high prevalence of atrophic gastritis (24%), intestinal metaplasia (67%), mild-to-moderate dysplasia (8%), and severe dysplasia (0.6%).
  • Surveillance rates varied significantly: 26% for atrophic gastritis, 28% for intestinal metaplasia, 38% for mild-to-moderate dysplasia, and 61% for severe dysplasia.
  • Annual gastric cancer incidence within 5 years was 0.1% (atrophic gastritis), 0.25% (intestinal metaplasia), 0.6% (mild-to-moderate dysplasia), and 6% (severe dysplasia).
  • Risk factors for gastric cancer included increasing lesion severity (severe dysplasia HR 40.14), advanced age, and male gender.

Conclusions:

  • Patients with premalignant gastric lesions exhibit a considerable risk of gastric cancer.
  • Current surveillance strategies are not aligned with the identified cancer risks.
  • There is a clear need for the development of evidence-based guidelines for endoscopic surveillance in these patients.